Linking the VPS35 and EIF4G1 pathways in Parkinson's disease
Owen A Ross1, Casey Cook1, Leonard Petrucelli1
1Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
Neuron
|January 9, 2015
Summary
Understanding Parkinson's disease (PD) requires identifying its causes. A new study links VPS35 and EIF4G1 proteins, crucial for neurodegeneration in PD.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Parkinson's disease (PD) pathogenesis remains incompletely understood, hindering targeted drug development.
- Alpha-synuclein aggregation is a key hallmark of neurodegeneration in PD.
Purpose of the Study:
- To investigate the roles of VPS35 and EIF4G1 in alpha-synuclein-related neurodegeneration.
- To establish a link between VPS35 and EIF4G1 in the context of PD.
Main Methods:
- Utilized a yeast model system to study protein interactions and neurodegenerative pathways.
- Investigated the functional relationship between VPS35 and EIF4G1 in relation to alpha-synuclein toxicity.
Main Results:
- Established a significant link between VPS35 and EIF4G1 in the context of alpha-synuclein-related neurodegeneration.
- The study provides novel insights into the molecular mechanisms underlying PD pathogenesis.
Conclusions:
- VPS35 and EIF4G1 play critical roles in pathways leading to neurodegeneration in Parkinson's disease.
- This research opens new avenues for exploring therapeutic targets for PD by focusing on these protein interactions.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
4
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
4
01:15Parkinson's Disease: Overview
2.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.5K
01:24Parkinson Disease l: Introduction
3
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
3
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:23Alzheimer Disease ll: Pathophysiology
1
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
1
01:11IP3/DAG Signaling Pathway
16.2K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
16.2K